Mednax (NYSE:MD) traded today at a new 52-week high of $72.37. Approximately 337,000 shares have changed hands today, as compared to an average 30-day volume of 576,000 shares.
Mednax (NYSE:MD) has potential upside of 5.1% based on a current price of $72.16 and analysts' consensus price target of $75.86. The stock should discover initial support at its 50-day moving average (MA) of $67.05 and subsequent support at its 200-day MA of $60.16.
Mednax share prices have moved between a 52-week high of $72.37 and a 52-week low of $49.82 and are now trading 45% above that low price at $72.16 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has risen 0.4%.
MEDNAX, Inc., through a subsidiary, provides physician management services to hospital-based neonatal, maternal - fetal, pediatric cardiology, and pediatric intensive care specialties. The Company also manages anesthesia practices.